Experience of faculty and postgraduates on informed consent process from tertiary medical teaching institutions in South India – a multicentre study
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2021 - 2025
Project Lead
Dr Savitha D
Authors
Savitha D, Ashwini K Shetty, Geetha S, Johnson-Pradeep Ruben, Tinku Thomas, Jayanti Savio, Manjulika Vaz.
Project Status
ongoing
Project Type
Original Research Article